Moreover, our present findings not only enhanced the understanding of RNF180 as an anti-oncogene in the progression of lung cancer but also provided evidences to indicate its potential role and molecule pathway as a potential target in developing the therapy for human lung cancer. The gene discussed is RNF180; the disease is lung cancer.